Results 11,961-11,980 of 49,836 for speaker:Stephen Donnelly
- Written Answers — Department of Health: Primary Care Services (5 Nov 2020)
Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.
- Written Answers — Department of Health: National Treatment Purchase Fund (5 Nov 2020)
Stephen Donnelly: The National Treatment Purchase Fund (NTPF) procures capacity for high-volume procedures in order to positively impact waiting time for patients. Such procedures may be procured in both private hospitals (outsourcing), or public hospitals (insourcing). In order to ensure competitive pricing as part of their outsourcing programme, the NTPF works with private hospitals from a panel agreement...
- Written Answers — Department of Health: Hospital Groups (5 Nov 2020)
Stephen Donnelly: In relation to the matter raised by the Deputy the National Treatment Purchase Fund (NTPF) have provided the attached table. It provides a breakdown by Hospital Group of actual amounts paid by the NTPF in respect of treatment invoiced and paid for in 2017, 2018 and 2019 and to the end of October 2020. The NTPF has advised that the amounts shown do not include treatment which took place in the...
- Written Answers — Department of Health: Hospital Waiting Lists (5 Nov 2020)
Stephen Donnelly: In order to ensure the accuracy of waiting lists, good practice around the management of hospital waiting lists recommends periodic validation of waiting lists. Validation is the process whereby hospital administration contacts patients on waiting lists at pre-planned intervals during the year to ensure that patients are ready, willing, suitable and available to attend a hospital appointment...
- Written Answers — Department of Health: Medical Cards (5 Nov 2020)
Stephen Donnelly: As this is a service matter, it has been referred to the Health Service Executive for attention and direct reply to the Deputy.
- Written Answers — Department of Health: Hospital Data (5 Nov 2020)
Stephen Donnelly: I propose to take Questions Nos. 259 and 260 together. As the Deputy's specific questions refer to the numbers of patients with delayed transfers of care and the associated numbers of bed days lost, I have asked the HSE to respond directly with the requested information.
- Written Answers — Department of Health: Ambulance Service (5 Nov 2020)
Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
- Written Answers — Department of Health: Emergency Departments (5 Nov 2020)
Stephen Donnelly: With regard to the Deputy's specific question, I have asked the HSE to respond directly with the requested information.
- Written Answers — Department of Health: Ambulance Service (5 Nov 2020)
Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
- Written Answers — Department of Health: Hospital Waiting Lists (5 Nov 2020)
Stephen Donnelly: In relation to the particular query raised, as this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.
- Written Answers — Department of Health: Hospital Waiting Lists (5 Nov 2020)
Stephen Donnelly: I propose to take Questions Nos. 265 to 306, inclusive, together. The HSE advises that a pilot project commenced in 2016 by HSE Acute Hospitals Division to progress the collection of national radiology waiting list data. The project has been supported by the Radiology Clinical Care Programme and has involved key stakeholders across the system including the National Integrated Medical Imaging...
- Written Answers — Department of Health: Nursing Staff (5 Nov 2020)
Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond directly to the Deputy, as soon as possible.
- Written Answers — Department of Health: Covid-19 Pandemic (5 Nov 2020)
Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.
- Written Answers — Department of Health: Covid-19 Pandemic (5 Nov 2020)
Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.
- Written Answers — Department of Health: Neuro-Rehabilitation Services (5 Nov 2020)
Stephen Donnelly: You will be aware that the situation regarding COVID-19 has been, and continues to be, an evolving situation. COVID-19 is still having a major impact both here in Ireland and elsewhere. On Tuesday 15 September the Government published ‘Resilience and Recovery 2020-2021: Plan for Living with COVID-19’. This Plan outlines our medium-term strategy for COVID-19 and sets out a...
- Written Answers — Department of Health: Health Services (5 Nov 2020)
Stephen Donnelly: It is recognised that waiting times for scheduled appointments and procedures have been impacted as a direct result of the COVID-19 pandemic. In response to the Covid-19 pandemic the HSE had to take measures to defer most scheduled care activity in March, April, and May of this year. This was to ensure patient safety and that all appropriate resources were made available for Covid-19...
- Written Answers — Department of Health: Healthcare Policy (5 Nov 2020)
Stephen Donnelly: The Minister for Health has received correspondence and a reply will issue in due course.
- Written Answers — Department of Health: Health Services (5 Nov 2020)
Stephen Donnelly: It is recognised that waiting times for scheduled appointments and procedures have been impacted as a direct result of the COVID-19 pandemic. In response to the Covid-19 pandemic the HSE had to take measures to defer most routine scheduled care activity in March, April, and May of this year. This was to ensure patient safety and that all appropriate resources were made available for...
- Written Answers — Department of Health: Medicinal Products (5 Nov 2020)
Stephen Donnelly: Following a request from the HSE Drugs Group the HSE Rare Diseases Medicinal Products Technology Review Committee convened on 24 September to engage with patients and clinicians in the assessment of two drugs. These are: 1. Burosumab (Crysvita®) for the treatment of X-linked hypophosphataemia with radiographic evidence of bone disease in children 1 year of age and older and adolescents...
- Written Answers — Department of Health: Stroke Care (5 Nov 2020)
Stephen Donnelly: This question is further to a Parliamentary Question (No. 768 of September 2020) that was referred to the HSE.